NYKODE THERAPEUTICS ASA

Operating

Home - Nykode

The Nykode Therapeutics platform is built around the Vaccibody molecule: A vaccine platform for the future of medicine.

Utvikling av biomedisinske produkter og tjenester. Formålet kan fremmes ved deltagelse i eller samarbeid med andre foretak i inn- og utland eller rådgivende virksomhet.

Utvikling av bio-medisinske produkter.

Organization

CEO: MT
Michael Thyrring Engsig1972
Chairman of the board: BH
Barbara Helene Hannelore Krebs-Pohl1968
Years since formation: 19 years; since Jan 13, 2007
Type: Public limited company
VAT registered: Yes
Number of employees: 48

Ownership

Number of shares and share classes: 326,546,444; 1 share class
Total number of shareholders: 7340; 922 companies, 6,418 persons

Financials

Total operating income 2025: 453,000; NOK
Annual total result 2025: -12,673,000; NOK
Total equity 2025: 94,977,000; NOK

Last update: Oct 13, 2026

Management

Management / administration

Name	Role	Shares
MT Michael Thyrring Engsig 1972	Managing Director/CEO	-

Board

Name	Role	Shares
BH Barbara Helene Hannelore Krebs-Pohl 1968	Chairman	-
CÅ Christian Åbyholm 1972	Board Member	-
TL Trygve Lauvdal 1969	Board Member	-
SS Susanne Stuffers 1981	Board Member	-
JW John William Beadle 1964	Board Member	-

Others

Name	Role	Shares
D DELOITTE AS	Auditor	-
A AMESTO ACCOUNTHOUSE AS	Accountant	-

Top 10 individual shareholders

Name	Role	Shares
HJ Haudemann-Andersen Jan 1958	-	4.95 % directly 0.07 % indirectly 4.88 %
AH Andenæs Hilde 1971	-	4.27 % indirectly
CH Caroline Haudemann-Andersen Alexandra 1989	-	3.95 % indirectly
AW Andenæs Westvold Una 2000	-	1.64 % indirectly
AW Andenæs Westvold Eva 2003	-	1.64 % indirectly
AW Andenæs Westvold Susanne 2007	-	1.6 % indirectly
FH Falck Halvorsen Una 2003	-	1.5 % indirectly
GS Grim Skorstad Ketil 1974	-	1.45 % indirectly
VH Vidar Haudemann-Andersen Stein 1955	-	1.37 % indirectly
ÅC Åbyholm Christian 1972	-	1 % indirectly

Last update: Feb 19, 2026

Ownership

Company shareholders

Name	Share class	Total number of shares	Share
R RASMUSSENGRUPPEN AS	Ordinary shares	30,180,750	9.24 %
D DATUM OPPORTUNITY AS	Ordinary shares	26,000,000	7.96 %
V VICTORIA INDIA FUND AS	Ordinary shares	17,705,175	5.42 %
N NORDA ASA	Ordinary shares	15,996,755	4.9 %
D DATUM AS	Ordinary shares	12,560,250	3.85 %
J JOH JOHANNSON EIENDOM AS	Ordinary shares	10,561,631	3.23 %
R RADFORSK INVESTERINGSSTIFTELSE	Ordinary shares	7,065,311	2.16 %
O OM HOLDING AS	Ordinary shares	4,919,525	1.51 %
P PORTIA AS	Ordinary shares	4,500,000	1.38 %
K KRAG INVEST AS	Ordinary shares	4,470,100	1.37 %
AH Aarvold Hofland Christian 1986	Ordinary shares	2,853,366	0.87 %
V VERDIPAPIRFONDET KLP AKSJENORGE INDEKS	Ordinary shares	2,783,251	0.85 %
A ALDEN AS	Ordinary shares	2,550,000	0.78 %
D DATUM FINANS AS	Ordinary shares	2,395,500	0.73 %
C CAABY AS	Ordinary shares	2,155,295	0.66 %
R RTTM HOLDING AS	Ordinary shares	2,056,496	0.63 %
F FOUGNER INVEST AS	Ordinary shares	2,004,477	0.61 %
M MELESIO INVEST AS	Ordinary shares	2,000,000	0.61 %
A ACIER AS	Ordinary shares	2,000,000	0.61 %
V VERDIPAPIRFONDET DNB NORGE INDEKS	Ordinary shares	1,921,383	0.59 %
V VIGINTI AS	Ordinary shares	1,882,900	0.58 %
B BORGANO AS	Ordinary shares	1,875,000	0.57 %
C CIPRIANO AS	Ordinary shares	1,775,000	0.54 %
H HIFO INVEST AS	Ordinary shares	1,766,666	0.54 %
T TIGERSTADEN INVEST AS	Ordinary shares	1,750,000	0.54 %
L LIVERMORE INVEST AS	Ordinary shares	1,700,000	0.52 %
BB Bogen Bjarne 1951	Ordinary shares	1,609,741	0.49 %
H HAADEM INVEST AS	Ordinary shares	1,600,000	0.49 %
T TIGERSTADEN AS	Ordinary shares	1,498,641	0.46 %
C CRESSIDA AS	Ordinary shares	1,350,000	0.41 %
S Sirius AS	Ordinary shares	1,250,000	0.38 %
H HORTULAN AS	Ordinary shares	1,130,000	0.35 %
EP Edward Pike Tom 1960	Ordinary shares	1,120,831	0.34 %
FJ Fredriksen Jostein 1976	Ordinary shares	1,100,000	0.34 %
GØ Grotmol Øyvind 1980	Ordinary shares	1,083,747	0.33 %
CY Churk Yue Yip Timothy 1971	Ordinary shares	1,078,452	0.33 %
K KOMMUNAL LANDSPENSJONSKASSE GJENSIDIG FORSIKRINGSSELSKAP	Ordinary shares	1,074,917	0.33 %
J JOF INVEST AS	Ordinary shares	1,000,000	0.31 %
A ALUNDO INVEST AS	Ordinary shares	1,000,000	0.31 %
L LITHINON AS	Ordinary shares	1,000,000	0.31 %
S SP CAPITAL 22 AS	Ordinary shares	1,000,000	0.31 %
SP Sandvik Pedersen Atle 1966	Ordinary shares	1,000,000	0.31 %
S STAFF-GRUPPEN AS	Ordinary shares	1,000,000	0.31 %
K KRISTIAN FALNES AS Closed	Ordinary shares	950,000	0.29 %
S SONGA CAPITAL AS	Ordinary shares	948,979	0.29 %
V VERDIPAPIRFONDET STOREBRAND INDEKS - NORGE	Ordinary shares	934,849	0.29 %
F FINYIELD AS	Ordinary shares	915,000	0.28 %
A ACADIA HOLDING AS	Ordinary shares	885,000	0.27 %
C CATILINA INVEST AS	Ordinary shares	851,739	0.26 %
T TRIONOR AS	Ordinary shares	840,000	0.26 %
V VERDIPAPIRFONDET EQUINOR AKSJER NORGE	Ordinary shares	822,600	0.25 %
R RAMS AS	Ordinary shares	800,000	0.24 %
S STRIGEN AS	Ordinary shares	770,000	0.24 %
F FACULTAS AS	Ordinary shares	762,500	0.23 %
A AUGUST HOLDING AS	Ordinary shares	750,000	0.23 %
N NASA AS	Ordinary shares	750,000	0.23 %
N NORDNET LIVSFORSIKRING AS	Ordinary shares	724,810	0.22 %
S STARSHIP AS	Ordinary shares	700,000	0.21 %
RO Rongevær Otto 1955	Ordinary shares	671,575	0.21 %
S SPÅLEN GENERASJON AS	Ordinary shares	650,000	0.2 %
V VERDIPAPIRFONDET DNB AM NORSKE AKSJER	Ordinary shares	641,834	0.2 %
V VERDIPAPIRFONDET ALFRED BERG INDEKS	Ordinary shares	607,000	0.19 %
K KRANSTAD INVEST AS	Ordinary shares	600,000	0.18 %
E EHTROD HOLDING AS	Ordinary shares	598,239	0.18 %
G GUNNAR LANDGRAFF AS	Ordinary shares	550,000	0.17 %
AI Alfheim Ingrid 1946	Ordinary shares	500,434	0.15 %
K KLØVNINGEN AS	Ordinary shares	500,000	0.15 %
R RIVERTOWN TRADING AS	Ordinary shares	500,000	0.15 %
K KARL A HARALDSEN 1 AS	Ordinary shares	500,000	0.15 %
RR Roar Rønning Jan 1978	Ordinary shares	500,000	0.15 %
C CAJO INVEST AS	Ordinary shares	500,000	0.15 %
T TIGERGUTT INVEST AS	Ordinary shares	500,000	0.15 %
A AREPO AS	Ordinary shares	500,000	0.15 %
V VEGAR GIÆVER HOLDING AS	Ordinary shares	478,556	0.15 %
E EMERALD INVEST AS	Ordinary shares	470,000	0.14 %
P PE UNITED AS	Ordinary shares	455,090	0.14 %
L LYNX UNLIMITED AS	Ordinary shares	454,020	0.14 %
S SPARLI AS	Ordinary shares	451,000	0.14 %
A AMBROSIA AS	Ordinary shares	450,312	0.14 %
H HAUG INVEST AS	Ordinary shares	450,000	0.14 %
H H5 VEKST AS	Ordinary shares	436,488	0.13 %
S STRØMME GRUPPEN AS	Ordinary shares	430,000	0.13 %
AJ Anton Johnsen Jarle 1953	Ordinary shares	421,695	0.13 %
G GEKKO AS	Ordinary shares	402,000	0.12 %
E ELAR CONSULTING AS	Ordinary shares	400,000	0.12 %
L LBM INVEST AS	Ordinary shares	400,000	0.12 %
W WESSEL SKIBS AS	Ordinary shares	400,000	0.12 %
S STOKO AS	Ordinary shares	400,000	0.12 %
C CAMELBACK HOLDING AS	Ordinary shares	395,000	0.12 %
M MARTINSEN MANAGEMENT AS	Ordinary shares	388,850	0.12 %
C CAMP MYRVOLD AS	Ordinary shares	386,240	0.12 %
A AMANDATOR AS	Ordinary shares	382,961	0.12 %
PB Pedersen Bjørn 1962	Ordinary shares	380,000	0.12 %
S SPAR KAPITAL INVESTOR AS	Ordinary shares	379,659	0.12 %
U UFI CAPITAL AS	Ordinary shares	370,000	0.11 %
P PRO AS	Ordinary shares	368,270	0.11 %
S SØSTRENE FRIIS AS	Ordinary shares	360,000	0.11 %
T TYRANNUS AS	Ordinary shares	350,000	0.11 %
P PILLAGE 3 AS	Ordinary shares	350,000	0.11 %
T TTC INVEST AS	Ordinary shares	340,000	0.1 %

Last update: Sep 25, 2026

Financials

in NOK

Summary

Year	2025	2024	2023	2022	2021
Total operating income	453,000	9,158,000	13,362,000	9,029,000	35,766,000
Annual Total Result	-12,673,000	-38,479,000	-33,392,000	-41,680,000	-8,597,000
Total assets	102,717,000	156,082,000	210,353,000	223,706,000	265,755,000
Total liabilities	7,740,000	15,940,000	35,521,000	64,880,000	70,888,000
Total equity	94,977,000	140,142,000	174,832,000	158,826,000	194,866,000

P&L

Year	2025	2024	2023	2022	2021
Total operating income	453,000	9,158,000	13,362,000	9,029,000	35,766,000
Total operating costs	29,615,000	54,906,000	69,842,000	61,177,000	45,682,000
Operating result	-29,162,000	-45,748,000	-56,480,000	-52,148,000	-9,916,000
Financial income/costs	10,988,000	547,000	14,051,000	2,148,000	-412,000
Profit before tax	-18,174,000	-45,201,000	-42,429,000	-50,000,000	-10,328,000
Total tax & extraordinary income/cost	-5,501,000	-6,722,000	-9,037,000	-8,320,000	-1,731,000
Annual Total Result	-12,673,000	-38,479,000	-33,392,000	-41,680,000	-8,597,000

Balance overview

Year	2025	2024	2023	2022	2021
Total fixed assets	42,069,000	40,494,000	45,910,000	12,636,000	10,527,000
Total current assets	60,648,000	115,588,000	164,443,000	211,070,000	255,228,000
Total assets	102,717,000	156,082,000	210,353,000	223,706,000	265,755,000
Short term debt	5,790,000	8,083,000	19,855,000	39,406,000	30,754,000
Long term debt	1,950,000	7,857,000	15,666,000	25,474,000	40,134,000
Total liabilities	7,740,000	15,940,000	35,521,000	64,880,000	70,888,000
Contributed capital	112,612,000	144,922,000	141,633,000	83,656,000	89,708,000
Retained earnings	-17,635,000	-4,780,000	33,199,000	75,170,000	105,158,000
Total equity	94,977,000	140,142,000	174,832,000	158,826,000	194,866,000
Total equity and liabilities	102,717,000	156,082,000	210,353,000	223,706,000	265,754,000

Classification

21st company classification

BETA

Industrial large enterprise

Type of organization

Public limited company

Classification of institutional sector

INNL

Domestic sectors

A_IKKE-FIN

Non-financial corporations

2100

Private non-financial incorporated enterprises

Standard industrial classification

NYKODE THERAPEUTICS ASA990 646 066